J Physiol Wellcome Trust-funded researchers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Physiol Vol 411 pp 45-52
Copyright © 1989 by The Physiological Society
This Article
Right arrow Full Text (PDF)
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lang, D
Right arrow Articles by Lewis, M J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lang, D
Right arrow Articles by Lewis, M J

Endothelium-derived relaxing factor inhibits the formation of inositol trisphosphate by rabbit aorta.

D Lang and M J Lewis

Department of Pharmacology, University of Wales College of Medicine, Heath Park, Cardiff.

1. The effects of endothelium-derived relaxing factor (EDRF), sodium nitroprusside, 8-bromo-cyclic GMP and atrial natriuretic factor (ANF) on inositol trisphosphate (IP3) levels were studied in isolated rabbit aortic preparations stimulated with noradrenaline. 2. In endothelium-containing preparations, acetylcholine, which stimulated EDRF release, inhibited noradrenaline-stimulated IP3 formation. The EDRF inhibitor haemoglobin reversed this effect. 3. In endothelium-denuded preparations, sodium nitroprusside, 8-bromo-cyclic GMP and ANF each similarly inhibited the rise in IP3 levels stimulated by noradrenaline. 4. These findings show that in rabbit aorta, agents which increase cyclic GMP inhibit the noradrenaline-induced rise in IP3 levels and may provide an explanation for the previously reported observations that cyclic GMP inhibits the noradrenaline-stimulated increase in calcium influx and release of intracellular calcium in vascular smooth muscle.




This article has been cited by other articles:


Home page
Circ. Res.Home page
R. A. Cohen, R. M. Weisbrod, M. Gericke, M. Yaghoubi, C. Bierl, and V. M. Bolotina
Mechanism of Nitric Oxide–Induced Vasodilatation : Refilling of Intracellular Stores by Sarcoplasmic Reticulum Ca2+ ATPase and Inhibition of Store-Operated Ca2+ Influx
Circ. Res., February 5, 1999; 84(2): 210 - 219.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. Ichihara, J. D. Imig, E. W. Inscho, and L. G. Navar
Interactive Nitric Oxide–Angiotensin II Influences on Renal Microcirculation in Angiotensin II–Induced Hypertension
Hypertension, June 1, 1998; 31(6): 1255 - 1260.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
G. Kojda, M. Patzner, A. Hacker, and E. Noack
Nitric Oxide Inhibits Vascular Bioactivation of Glyceryl Trinitrate: A Novel Mechanism to Explain Preferential Venodilation of Organic Nitrates
Mol. Pharmacol., March 1, 1998; 53(3): 547 - 554.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Ichihara, H. Kobori, Y. Miyashita, M. Hayashi, and T. Saruta
Differential effects of thyroid hormone on renin secretion, content, and mRNA in juxtaglomerular cells
Am J Physiol Endocrinol Metab, February 1, 1998; 274(2): E224 - E231.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. J. Baines, C. Brown, L. L. Ng, and M. R. Boarder
Angiotensin II–Stimulated Phospholipase C Responses of Two Vascular Smooth Muscle–Derived Cell Lines: Role of Cyclic GMP
Hypertension, November 1, 1996; 28(5): 772 - 778.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 The Physiological Society.